Genomatica secures lead investor to bring equity investments to $90m

By Becky Bargh 23-Oct-2018

Lead investors include Casdin Capital, Viking Global Investors and Ginkgo Bioworks

Chemical manufacturing company Genomatica has secured US$90m of equity investments following a drive to increase capital.

Participants include new lead investor . . .

This is a small extract of the full article which is available ONLY to premium content subscribers. Subscribers sign-in (top right) to read the article.

Or

Subscribe now to premium content on Cosmetics Business

Featured Companies

Genomatica (more information, website)

Subscriber Sign In

Subscriber Help

Related Articles

THG’s Moulding gives up ‘golden share’ following share price fall

Is the owner of Harrods buying rival Selfridges?

Legal 101: How to create a solid contract for beauty influencers

iNNBeauty Project puts minority investment funds towards Sephora launch

Fragrance and beauty drive Givaudan’s stirling performance in first 9 months

The Hut Group insists business is solid after shock share price fall

The smell of money: Mastercard has entered fragrance

Asos’ exiting CEO buys up fresh shares as confidence in business falls

Start-up Sequential Skin bags $1.65m of fresh funding

The Hut Group goes live with Bitcoin payments for all brand websites, beauty benefits

‘Boohoo don’t do shops, until now’: Debenhams returns to high street with dedicated beauty store

Related Product News

Genomatica closes $118m series C to amplify sustainable materials business

Genomatica names Glenn as exclusive distributor for natural ingredient Brontide